Select Publications
Journal articles
2022, 'Incorrect Knowledge of Event-Driven PrEP "2-1-1" Dosing Regimen Among PrEP-Experienced Gay and Bisexual Men in Australia', Journal of Acquired Immune Deficiency Syndromes, 90, pp. 132 - 139, http://dx.doi.org/10.1097/QAI.0000000000002935
,2022, 'Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia', AIDS and Behavior, 26, pp. 88 - 95, http://dx.doi.org/10.1007/s10461-021-03344-3
,2021, 'Renal impairment in a large-scale HIV preexposure prophylaxis implementation cohort', AIDS, 35, pp. 2319 - 2326, http://dx.doi.org/10.1097/QAD.0000000000003035
,2021, 'Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia', AIDS, 35, pp. 1987 - 1996, http://dx.doi.org/10.1097/QAD.0000000000002970
,2021, 'Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: A multi-methods cross-sectional study', International Journal of Infectious Diseases, 110, pp. S17 - S24, http://dx.doi.org/10.1016/j.ijid.2021.04.077
,2021, 'High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data from the EPIC-NSW Trial', Journal of Acquired Immune Deficiency Syndromes, 87, pp. 1040 - 1047, http://dx.doi.org/10.1097/QAI.0000000000002691
,2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6
,2021, 'What does PrEP mean for 'safe sex' norms? A qualitative study', PLoS ONE, 16, pp. e0255731, http://dx.doi.org/10.1371/journal.pone.0255731
,2021, 'Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: Results from the MI-EPIC clinical trial', Sexual Health, 18, pp. 453 - 459, http://dx.doi.org/10.1071/SH21096
,2021, 'Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.', J Acquir Immune Defic Syndr, 86, pp. 22 - 30, http://dx.doi.org/10.1097/QAI.0000000000002514
,2020, 'Comparison of Trends in Rates of Sexually Transmitted Infections before vs after Initiation of HIV Preexposure Prophylaxis among Men Who Have Sex with Men', JAMA Network Open, 3, pp. e2030806, http://dx.doi.org/10.1001/jamanetworkopen.2020.30806
,2020, 'Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia', JAIDS Journal of Acquired Immune Deficiency Syndromes, Publish Ahead of Print, pp. 309 - 315, http://dx.doi.org/10.1097/qai.0000000000002462
,2020, 'Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine', AIDS and Behavior, 24, pp. 1400 - 1413, http://dx.doi.org/10.1007/s10461-019-02739-7
,2020, 'Use of HIV pre-exposure prophylaxis (PrEP) associated with lower HIV anxiety among gay and bisexual men in Australia who are at high risk of HIV infection', JAIDS Journal of Acquired Immune Deficiency Syndromes, 83, pp. 119 - 125, http://dx.doi.org/10.1097/qai.0000000000002232
,2020, 'Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia', International Journal of Drug Policy, 76, pp. 102659 - 102659, http://dx.doi.org/10.1016/j.drugpo.2019.102659
,2019, 'High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE', AIDS and Behavior, 23, pp. 1780 - 1789, http://dx.doi.org/10.1007/s10461-018-2290-3
,2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project', AIDS and Behavior, 23, pp. 1287 - 1296, http://dx.doi.org/10.1007/s10461-018-2353-5
,2019, 'Brief Report: Changes in Behavior after PrEP Initiation among Australian Gay and Bisexual Men', Journal of Acquired Immune Deficiency Syndromes, 81, pp. 52 - 56, http://dx.doi.org/10.1097/QAI.0000000000001976
,2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before-after study (vol 16, pg 172, 2019)', SEXUAL HEALTH, 16, pp. 299 - 299, http://dx.doi.org/10.1071/SH18161_CO
,2019, 'HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the non-use of PrEP among eligible men', JAIDS Journal of Acquired Immune Deficiency Syndromes, 81, pp. 1 - 1, http://dx.doi.org/10.1097/qai.0000000000002047
,2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before–after study', Sexual Health, 16, pp. 172 - 179, http://dx.doi.org/10.1071/sh18161
,2018, 'Qualitative Insights into Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Australian Gay and Bisexual Men', AIDS Patient Care and STDs, 32, pp. 519 - 528, http://dx.doi.org/10.1089/apc.2018.0106
,2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7
,2018, 'Age related prevalence and age related incidence of illicit drug use in a cohort of Australian gay and bisexual men: Results form the FLUX study', Drug and Alcohol Dependence, 188, pp. 175 - 179, http://dx.doi.org/10.1016/j.drugalcdep.2018.04.009
,2018, 'The new MTV generation: Using methamphetamine, Truvada and Viagra to enhance sex and stay safe.', International Journal of Drug Policy, 55, pp. 197 - 204, http://dx.doi.org/10.1016/j.drugpo.2018.02.021
,2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, 18, pp. 210, http://dx.doi.org/10.1186/s12889-017-5018-9
,2017, 'Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE Demonstration Project', PLoS One, 12, pp. e0185398, http://dx.doi.org/10.1371/journal.pone.0185398
,2017, 'Baseline preferences for daily, event-driven, or periodic hiv pre-exposure prophylaxis among gay and bisexual men in the prelude demonstration project', Frontiers in Public Health, 5, pp. 341, http://dx.doi.org/10.3389/fpubh.2017.00341
,2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, 6, pp. e012179corr1, http://dx.doi.org/10.1136/bmjopen-2016-012179
,2016, 'Barriers to care in gout: From prescriber to patient', Journal of Rheumatology, 43, pp. 144 - 149, http://dx.doi.org/10.3899/jrheum.150607
,2015, 'LB1.4 Sti rates among gay men taking daily antiretrovirals for pre-exposure prophylaxis of hiv: the nsw demonstration project prelude', Sexually Transmitted Infections, 91, pp. A78.2 - A78, http://dx.doi.org/10.1136/sextrans-2015-052270.209
,Conference Posters
2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c
,2019, 'The social media response to an Australian PrEP seroconversion', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/85842bc72f3443e5a878c2bbb5ea0541
,2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019
,2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018
,2017, '“Breakfast cereal, glass of orange juice and my PrEP”: A qualitative exploration of adherence and non-adherence to daily pre-exposure prophylaxis (PrEP)', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2017
,2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358
,2016, 'Use of behavioural eligibility criteria to identify high-HIV risk gay and bisexual men (GBM) for enrolment in a pre-exposure prophylaxis (PrEP) study in NSW, Australia', Durban, South Africa, presented at AIDS 2016, Durban, South Africa, 16 July 2016 - 21 July 2017, http://dx.doi.org/10.26190/unsworks/26284
,2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015
,2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014
,Conference Presentations
2019, 'USE OF HIV PRE-EXPOSURE PROPHYLAXIS (PREP) ASSOCIATED WITH LOWER HIV RELATED ANXIETY AMONG AUSTRALIAN GAY AND BISEXUAL MEN WHO ARE AT HIGH RISK OF HIV INFECTION.', presented at 2019 Joint Australasian Sexual Health and HIV/AIDS Conference, Perth, 16 September 2019 - 19 September 2019, http://dx.doi.org/10.26190/unsworks/27987
,2019, 'JUST ANOTHER TEST: STI TESTING FREQUENCIES OF GAY AND BISEXUAL MEN IN AUSTRALIA', presented at Australasian HIV & AIDS and Sexual Health Conferences, Perth, 16 September 2019 - 19 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/de49984ef1514138b7a4ee6fb1b96d35
,Conference Abstracts
2019, 'ANXIETY ABOUT HIV AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG GAY AND BISEXUAL MEN', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A209 - A210, http://dx.doi.org/10.1136/sextrans-2019-sti.529
,2019, 'ELIGIBILITY FOR AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG AUSTRALIAN GAY AND BISEXUAL MEN OVER TIME', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A209 - A209, http://dx.doi.org/10.1136/sextrans-2019-sti.527
,2019, 'USE OF CONDOMS FOR THE PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AMONG HIV PRE-EXPOSURE PROPHYLAXIS (PREP) USERS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A206 - A206, http://dx.doi.org/10.1136/sextrans-2019-sti.521
,2018, 'Baseline preferences for daily and non-daily PrEP dosing in EPIC-NSW', in Australasian HIV and AIDS Conference Handbook, Sydney, Australia, presented at Australasian HIV and AIDS Conference, Sydney, Australia, 26 September 2018, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/36f06f6908734ab9a17095cab8705e35
,2018, 'The new MTV generation: using methamphetamine, Truvada and Viagra to enhance sex and stay safe', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 114 - 115
,2017, 'The new MTV generation- Using Meth, Truvada, and Viagra to stay safe and enhance sex: Results from the Flux Study', in Australasian HIV/AIDS Conference Handbook, Canberra, presented at Australasian HIV/AIDS Conference, Canberra, 06 November 2017 - 10 November 2017
,2017, '“I Feel That I’m Finally Fully Enjoying Sex For The First Time In My Life”: The Impact Of Prep On Sexual Cultures From The SIN-Prep Study', in HIV/AIDS and and SH Abstracts, Canberra, presented at Australasian HIV/AIDS Conference, Canberra, 06 November 2017 - 09 November 2017
,2015, 'IDENTIFYING BARRIERS TO TREATING GOUT EFFECTIVELY: A QUALITATIVE STUDY OF PATIENTS' AND GENERAL PRACTITIONERS' UNDERSTANDING AND MANAGEMENT OF GOUT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,